India, April 5 -- US President Donald Trump has reportedly decided to not go ahead with predecessor Joe Biden's proposal of a rule that would have extended the coverage of high-demand obesity treatment drugs under the federal government's Medicare programme.

The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare's Part D prescription drug coverage, according to a news agency Associated Press report.

Medicare covers health care expenses mainly for people age 65 and older.

Joe Biden had proposed a rule in late November after Trump won re-election that would have extended coverage of drugs like Zepbound and Wegovy, however, the former US President's proposal was expensive, th...